Fundz

Xilis reported raising $16.5 Million in an initial SEC Form D filing, from an offering of $16.5 Million

PRIVATEJul 14, 2022

Amount Raised

$16.5 Million

$16.5 Million sold, per SEC Form D (first sale Jun 1, 2022)

Round Type

Venture

DurhamBiotechnologyHealthcare

Quick answer

Xilis raised $16.5 Million in a funding round, dated June 1, 2022. Xilis is based in Durham, North Carolina, United States.

How much did Xilis raise?
Xilis raised $16.5 Million in a funding round on June 1, 2022.
What does Xilis do?
Based in Durham, North Carolina, Xilis, Inc. is a biotechnology company developing a precision oncology platform that guides treatment decisions for oncologists to improve cancer care outcomes for patients and supports..
Where is Xilis based and how big is it?
Xilis is based in Durham, North Carolina, United States. Fundz records about 76 employees.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Xilis that raised within 45 days of this round, from Fundz verified event records.

  • Renibus Therapeutics raised $15M on July 15, 2022.
  • Greenbrook TMS raised $16M on July 14, 2022.
  • Ensysce Biosciences raised $4.2M (Seed) on July 8, 2022.
  • Kernal Biologics raised $25M (Series A) on July 7, 2022.
  • X4 Pharmaceuticals raised $56M on July 6, 2022.
  • Ascendia Pharmaceuticals raised $2.5M on July 1, 2022.

Who to call at Xilis, and when

A new round usually means Xilis is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Xilis raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Xilis, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Xilis. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Xilis

Location

31 ALEXANDRIA WAY

Durham, North Carolina, United States

About

Based in Durham, North Carolina, Xilis, Inc. is a biotechnology company developing a precision oncology platform that guides treatment decisions for oncologists to improve cancer care outcomes for patients and supports drug discovery and development for pharmaceutical companies. Xilis’ proprietary MicroOrganoSphere™ (MOS) technology consists of miniature patient tumors that capture the full microenvironment and heterogeneity and provides an automated and scalable solution. Using MOS and AI-driven algorithms, Xilis is developing a Xilis Response Score™ for the clinic, enabling oncologists to make informed and timely treatment decisions. Additionally, the MOS technology is speeding up development and clinical trials of cancer drugs by enabling analysis of authentic tumor microenvironments, high-throughput preclinical modeling, and clinical patient selection capabilities. About Mubadala Capital Mubadala Capital is the asset management arm of Mubadala Investment Company, a leading global sovereign investor headquartered in Abu Dhabi. In addition to managing its own balance sheet investments, Mubadala Capital manages third-party capital on behalf of institutional investors in four of its businesses, including three private equity funds, two early stage venture funds, a public fund and a fund in Brazil focused on special situations. The various businesses invest across the capital structure in both public and private securities. To learn more about Xilis, visit our website at www.Xilis.com or follow us on Twitter and LinkedIn.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Xilis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Xilis's next move

See what Strategic adds

Xilis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.